Form 4 for CYH COMMUNITY HEALTH SYSTEMS INC
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-014666 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-03-01 | CYH | SMITH WAYNE T | Dir | M - OptEx | $0.00 | +225.0K | 4.26M | +6% | $0 |
| D | 2023-03-02 | 2023-03-01 | CYH | SMITH WAYNE T | Dir | F - Tax | $6.15 | -126.9K | 4.14M | -3% | -$780.5K |
| D | 2023-03-02 | 2023-03-01 | CYH | SMITH WAYNE T | Dir | G - Gift | $0.00 | -30.1K | 4.11M | -0.7% | $0 |
| D | 2023-03-02 | 2023-03-01 | CYH | SMITH WAYNE T | Dir | M - OptEx | $0.00 | -225.0K | 0 | -100% | $0 |
| DM | 2023-03-02 | 2023-03-01 | CYH | SMITH WAYNE T | Dir | A - Grant | $6.15 | +72.4K | 72.4K | New | +$445.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 225,000 | $0.00 | 4,264,856 | D | — | — | (F1) The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020. |
| 2 | Common | Common Stock | 2023-03-01 | F | D | 126,905 | $6.15 | 4,137,951 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-01 | G | D | 30,050 | $0.00 | 4,107,901 | D | — | — | (F2) These shares were gifted to individuals who do not share the Reporting Person's household. |
| 4 | Derivative | Performance Based Restricted | 2023-03-01 | M | D | 225,000 | $0.00 | 0 | D | $0.00 · — to — | 225,000 Common Stock | (F1) The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2020 and 12/31/2022 (the "2020-2022 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2020-2022 Performance Period, the award vested on March 1, 2023 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2020. |
| 5 | Derivative | Restricted Stock Units | 2023-03-01 | A | A | 29,268 | $6.15 | 29,268 | D | $0.00 · — to — | 29,268 Common Stock | (F3) The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. |
| 6 | Derivative | Restricted Stock Units | 2023-03-01 | A | A | 43,089 | $6.15 | 72,357 | D | $0.00 · — to — | 43,089 Common Stock | (F4) The restricted stock units, which were granted as payment of the Reporting Person's additional annual stipend for serving as the Chair of the Board, vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. |